Cas:428471-30-1 5-Bromo-N,N-diethyl-2-methoxybenzenesulfonamide manufacturer & supplier

Chemical Name:5-Bromo-N,N-diethyl-2-methoxybenzenesulfonamide

CAS.NO:428471-30-1

Synonyms:5-Bromo-N,N-diethyl-2-methoxybenzenesulfonamide;Benzenesulfonamide, 5-bromo-N,N-diethyl-2-methoxy-

Molecular Formula:C₁₁H₁₆BrNO₃S

Molecular Weight:322.219

HS Code:2935009090

Physical and Chemical Properties:

Melting point:90-94ºC

Boiling point:409.5±55.0 °C at 760 mmHg

Density:1.4±0.1 g/cm3

Index of Refraction:1.544

PSA:54.99000

Exact Mass:321.003418

LogP:3.73

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 5-Bromo-N,N-diethyl-2-methoxybenzenesulfonamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzenesulfonamide, 5-bromo-N,N-diethyl-2-methoxy- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-Bromo-N,N-diethyl-2-methoxybenzenesulfonamide Use and application,5-Bromo-N,N-diethyl-2-methoxybenzenesulfonamide technical grade,usp/ep/jp grade.

Related News: Retrogenix holds two Queen��s Awards for Enterprise, the UK��s most prestigious acknowledgement of business performance. The company is headquartered near Manchester, UK, and has an office in Cambridge, MA. 5-Bromo-N,N-diethyl-2-methoxybenzenesulfonamide manufacturer Any South Korean citizen returning home who has been in Hubei Province within the past two weeks will be subject to 14 days of self-quarantine and monitoring, the government said. 5-Bromo-N,N-diethyl-2-methoxybenzenesulfonamide supplier Retrogenix holds two Queen��s Awards for Enterprise, the UK��s most prestigious acknowledgement of business performance. The company is headquartered near Manchester, UK, and has an office in Cambridge, MA. 5-Bromo-N,N-diethyl-2-methoxybenzenesulfonamide vendor This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment, Mankind Pharma Director of Marketing Sanjay Koul said in a statement. 5-Bromo-N,N-diethyl-2-methoxybenzenesulfonamide factory This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment, Mankind Pharma Director of Marketing Sanjay Koul said in a statement.